Results 21 to 30 of about 4,279 (197)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa

open access: yesAntibiotics, 2022
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by painful nodules, abscesses, and fistulas, localized to the areas of the folds where apocrine glands are present: the armpits, groin, inframammary region, and genital or
Elisa Molinelli   +11 more
doaj   +1 more source

Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review

open access: yesJournal of Global Antimicrobial Resistance, 2021
: Objectives: Dalbavancin is a long-lasting lipoglycopeptide active against Gram-positive bacteria, especially methicillin-resistant staphylococci. Few data are available on dalbavancin use for treatment of prosthetic joint infections (PJIs).
Morgan Matt   +15 more
doaj   +1 more source

The activity of glycopeptide antibiotics against resistant bacteria correlates with their ability to induce the resistance system. [PDF]

open access: yes, 2014
Glycopeptide antibiotics containing a hydrophobic substituent display the best activity against vancomycin-resistant enterococci, and they have been assumed to be poor inducers of the resistance system.
Hong, Hee-Jeon, Kwun, Min Jung
core   +2 more sources

A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections

open access: yesAntibiotics, 2023
Bone and joint infections (BJI) require prolonged antimicrobial treatment, leading to lengthy hospitalizations, high costs, the risk of nosocomial infections, and the development of antimicrobial resistance.
Dimitra Dimopoulou   +3 more
doaj   +1 more source

Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics [PDF]

open access: yes, 2009
Novel therapeutic strategies are urgently needed for the treatment of serious diseases caused by viral, bacterial and parasitic infections, because currently used drugs are facing the problem of rapidly emerging resistance.
Bernardini, F   +6 more
core   +1 more source

Dalbavancin to Complete a Prolonged Antibiotic Course for Persistent <i>Bacillus cereus</i> Bacteremia: A Case Report and Literature Review. [PDF]

open access: yesCase Rep Infect Dis
Bacillus cereus is a Gram‐positive, rod‐shaped facultative anaerobe commonly associated with gastrointestinal infections. Although typically regarded as a blood culture contaminant, B. cereus can cause severe infections, including bacteremia, in high‐risk patients.
Yetukuri J, Choi J, Darkow A.
europepmc   +2 more sources

Consolidating Russia and Eurasia Antibiotic Resistance Data for 1992–2014 Using Search Engine [PDF]

open access: yes, 2016
Background: The World Health Organization recognizes the antibiotic resistance problem as a major health threat in the 21st century. The paper describes an effort to fight it undertaken at the verge of two industries - healthcare and Data Science. One of
Alexander Bedenkov   +4 more
core   +8 more sources

Can we prevent antimicrobial resistance by using antimicrobials better? [PDF]

open access: yes, 2013
Since their development over 60 years ago, antimicrobials have become an integral part of healthcare practice worldwide. Recently, this has been put in jeopardy by the emergence of widespread antimicrobial resistance, which is one of the major problems ...
Brown   +27 more
core   +2 more sources

Multicenter clinical experience of real life Dalbavancin use in gram-positive infections

open access: yesInternational Journal of Infectious Diseases, 2019
Dalbavancin, a lipoglycopeptide with prolonged half-life approved for the treatment of acute bacterial skin and soft tissue infections, can be used for the treatment of infections caused by gram-positive bacteria requiring long term treatment such as ...
S. Wunsch   +8 more
doaj   +1 more source

Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report

open access: yesInternational Journal of Infectious Diseases, 2020
There is a paucity of literature on the use of dalbavancin, a long-acting lipoglycopeptide, in infective endocarditis. Existing case reports have investigated dalbavancin in endocarditis as a sequential treatment after clearance of bacteria from the ...
Aaron Hakim   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy